A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification
Clinical trial NCT01001806 · COMPLETED
Trial details
- NCT number
- NCT01001806
- Sponsor
- Frank A. Bucci, Jr., M.D.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2009-12-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.